The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Innovations / Novel technologies

Symetis ACURATE TF™ aortic bioprosthesis

EuroIntervention 2013;9:S107-S110. DOI: 10.4244/EIJV9SSA22

1. Kerckhoff Heart and Thorax Centre, Bad Nauheim, Germany; 2. Universitäres Herzzentrum Hamburg, Hamburg, Germany; 3. Universitätsklinikum Bonn, Bonn, Germany; 4. Universitäres Herzzentrum Köln, Cologne, Germany; 5. Institute Dante Paz

The success of the innovative Symetis ACURATE TA aortic bioprosthesis triggered the development of a new TAVI device, in which the specific features are translated for a transfemoral approach. T

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
The Colibri heart valve: theory and practice in the achievement of a low-profile, pre-mounted, pre-packaged TAVI valve